BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

832 related articles for article (PubMed ID: 23871935)

  • 1. Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes.
    Nadal-Serrano M; Pons DG; Sastre-Serra J; Blanquer-Rosselló Mdel M; Roca P; Oliver J
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2045-51. PubMed ID: 23871935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol.
    Nadal-Serrano M; Sastre-Serra J; Pons DG; Miró AM; Oliver J; Roca P
    J Cell Biochem; 2012 Oct; 113(10):3178-85. PubMed ID: 22615145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio.
    Pons DG; Nadal-Serrano M; Blanquer-Rossello MM; Sastre-Serra J; Oliver J; Roca P
    J Cell Biochem; 2014 May; 115(5):949-58. PubMed ID: 24375531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents.
    Pons DG; Torrens-Mas M; Nadal-Serrano M; Sastre-Serra J; Roca P; Oliver J
    Int J Biochem Cell Biol; 2015 Sep; 66():85-94. PubMed ID: 26232188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio.
    Pons DG; Nadal-Serrano M; Torrens-Mas M; Oliver J; Roca P
    J Cell Biochem; 2016 Jan; 117(1):218-29. PubMed ID: 26100284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17β-Estradiol regulates oxidative stress in prostate cancer cell lines according to ERalpha/ERbeta ratio.
    Miró AM; Sastre-Serra J; Pons DG; Valle A; Roca P; Oliver J
    J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):133-9. PubMed ID: 21172438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oxidative stress in breast tumors of postmenopausal women is ERα/ERβ ratio dependent.
    Sastre-Serra J; Nadal-Serrano M; Pons DG; Valle A; Garau I; García-Bonafé M; Oliver J; Roca P
    Free Radic Biol Med; 2013 Aug; 61():11-7. PubMed ID: 23499841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phytoestrogen genistein affects inflammatory-related genes expression depending on the ERα/ERβ ratio in breast cancer cells.
    Pons DG; Vilanova-Llompart J; Gaya-Bover A; Alorda-Clara M; Oliver J; Roca P; Sastre-Serra J
    Int J Food Sci Nutr; 2019 Dec; 70(8):941-949. PubMed ID: 30945577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein.
    Sotoca AM; Gelpke MD; Boeren S; Ström A; Gustafsson JÅ; Murk AJ; Rietjens IM; Vervoort J
    Mol Cell Proteomics; 2011 Jan; 10(1):M110.002170. PubMed ID: 20884965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of 17β-estradiol on mitochondrial biogenesis and function in breast cancer cell lines are dependent on the ERα/ERβ ratio.
    Sastre-Serra J; Nadal-Serrano M; Pons DG; Valle A; Oliver J; Roca P
    Cell Physiol Biochem; 2012; 29(1-2):261-8. PubMed ID: 22415095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
    Power KA; Thompson LU
    Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
    Rajah TT; Du N; Drews N; Cohn R
    Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue.
    Evers NM; van de Klundert TM; van Aesch YM; Wang S; de Roos WK; Romano A; de Haan LH; Murk AJ; Ederveen AG; Rietjens IM; Groten JP
    Toxicol In Vitro; 2013 Sep; 27(6):1753-61. PubMed ID: 23680332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive effects of trastuzumab and genistein on human breast cancer cells.
    Lattrich C; Lubig J; Springwald A; Goerse R; Ortmann O; Treeck O
    Anticancer Drugs; 2011 Mar; 22(3):253-61. PubMed ID: 21160418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.
    Chang EC; Charn TH; Park SH; Helferich WG; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Endocrinol; 2008 May; 22(5):1032-43. PubMed ID: 18258689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The over-expression of ERbeta modifies estradiol effects on mitochondrial dynamics in breast cancer cell line.
    Sastre-Serra J; Nadal-Serrano M; Pons DG; Roca P; Oliver J
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1509-15. PubMed ID: 23618876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
    Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio.
    Sotoca AM; Ratman D; van der Saag P; Ström A; Gustafsson JA; Vervoort J; Rietjens IM; Murk AJ
    J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):171-8. PubMed ID: 18955141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.